Top

Journal of Neuro-Oncology

Published in:

Open Access 10-08-2023 | Regorafenib | Correspondence

Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib

Author: Aaron Lawson McLean

Published in: Journal of Neuro-Oncology | Issue 1/2023

Excerpt

To the Editor, …

Caccese M, Desideri I, Padovan M, Bruno F, Cerretti G, Fiorentino A, Denaro L, Chioffi F, Della Puppa A, Maccari M, Cavallin F, Coppola M, Pittaro A, Ruda R, Livi L, Lombardi G (2023) Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study. J Neurooncol 163:377–383. https://doi.org/10.1007/s11060-023-04356-wCrossRefPubMedPubMedCentral

Liu Y-C, Yeh C-T, Lin K-H (2019) Molecular functions of thyroid hormone signaling in regulation of Cancer Progression and Anti-Apoptosis. Int J Mol Sci 20. https://doi.org/10.3390/ijms20204986

Samuels MH, Schuff KG, Carlson NE, Carello P, Janowsky JS (2007) Health Status, Mood, and Cognition in Experimentally Induced Subclinical Hypothyroidism. J Clin Endocrinol Metabolism 92:2545–2551. https://doi.org/10.1210/jc.2007-0011CrossRef

Title: Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib
Author: Aaron Lawson McLean
Publication date: 10-08-2023
Publisher: Springer US
Keywords: Regorafenib
Glioblastoma
Glioblastoma
Glioblastoma
Published in: Journal of Neuro-Oncology / Issue 1/2023
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-023-04408-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center

Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis

Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis

Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma

Long-term follow up of patients with WHO grade 2 oligodendroglioma

Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis